ArticleBritish journal of clinical pharmacology2020

Population pharmacokinetics of adalimumab biosimilar adalimumab-adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity.

Jia Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.